FDA Alerts Hospitals to Recall of Nova StatStrip Gen 2.0 Glucose Meters Over Patient ID Errors
The US Food and Drug Administration alerted healthcare facilities that Nova Biomedical is recalling its StatStrip Glucose Hospital Meter System Gen 2.0 models. The FDA identified this as the most serious type of recall because using the device may cause severe injury or death. When hospital staff scan a patient barcode, earlier information can stay on the screen. If accepted by staff, blood sugar results can attach to the wrong person's medical chart. This error can cause medical teams to delay care or give dangerous treatments, such as unnecessary insulin. The problem does not change how accurately the meter measures blood sugar. As of October 5, 2026, Nova Biomedical had received reports of one serious injury and zero deaths linked to the issue. Nova has placed a shipment hold on the devices and advised hospitals with alternate equipment to stop using the Gen 2.0 meters while awaiting a software update scheduled for November 2026.
What was announced
The FDA MedWatch Safety Alerts service shared a recall notice on October 20, 2026, regarding Nova Biomedical StatStrip Glucose Hospital Meter Systems. The company recommended that healthcare sites remove its Gen 2.0 hospital meters from use until a software update is available. This action covers model number 63685 and the multipack model number 66739. Earlier models, such as the Gen 1.86, are not part of the recall.
Nova Biomedical reported that prior patient data can stay on the screen when an operator scans a new patient or Quality Control barcode. A Quality Control barcode is a label used when testing the machine with known reference solutions to verify its accuracy. If an operator confirms the leftover details, the meter logs the fresh test result under the wrong patient profile. Nova Biomedical placed a shipment hold on Gen 2.0 systems while it validates a software update, which it plans to release in November 2026.
What it means
The physical glucose test itself remains accurate. Nova Biomedical stated the fault is in how the meter displays and records identification data across all firmware versions of the Gen 2.0 model.
When a test result is saved to the wrong chart, doctors and nurses might treat someone based on another person's numbers. A patient might receive insulin they do not need, or miss treatment for dangerously high or low blood sugar. The announcement pointed out that infants and critically ill patients face the highest risk because they cannot easily speak up about low blood sugar symptoms.
Nova Biomedical told customers with replacement devices to stop using the Gen 2.0 meters. Facilities without back-up meters must follow manual safety steps. Staff must visually check patient details before and after every test, set NovaNet software to log operators out after every test, and turn on patient validation settings if their electronic medical record system allows it.
What the announcement does not tell us
The notice does not reveal the details of the single serious injury reported up to October 5, 2026. It does not state how many total devices are currently in use, or which specific hospitals have them. The announcement also does not give an exact day in November 2026 for when the software update will finish validation or reach hospitals.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.
Software update for StatStrip Glucose Hospital Meter Systems due to the potential for glucose results to be assigned to the incorrect patient.
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.